Gene expression profiles of microvascular endothelial cells after stimuli implicated in the pathogenesis of vasoocclusion

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 1, 2003, Pages 70-81

  Zachlederova, Marie ^a,b   Jarolim, Petr ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Adhesion; cDNA array; Gene expression; IL 1 ; Microvascular endothelial cells; Phosphatidylserine; Sickle cell anemia; TNF ; Transcriptional profile; Vasoocclusive crisis

Indexed keywords

INTERLEUKIN 1BETA; PHOSPHATIDYLSERINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; ERYTHROCYTE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SICKLE CELL ANEMIA;

EID: 0037234896     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00011-1     Document Type: Article

References (47)

1. Hebbel R.P. Adhesive interactions of sickle erythrocytes with endothelium. J. Clin. Invest. 99:1997;2561-2564.
2. Solovey A., et al. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337:1997;1584-1590.
3. Solovey A., et al. Tissue factor expression by endothelial cells in sickle cell anemia. J. Clin. Invest. 101:1998;1899-1904.
4. Solovey A., et al. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells . Blood. 93:1999;3824-3830.
5. Phelan M., et al. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J. Clin. Invest. 96:1995;1145-1151.
6. Shiu Y.-T., Udden M.M., McIntire L.V. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. Blood. 95:2000;3232-3241.
7. Wood B.L., Gibson D.F., Tait J.F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease flow-cytometric measurement and clinical associations . Blood. 88:1996;1873-1880.
8. Closse C., Dachary-Prigent J., Boisseau M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol. 107:1999;300-302.
9. Setty B.N.Y., Kulkarni S., Stuart J.M. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood. 99:2002;1564-1571.
10. Makis A.C., Hatzimichael E.C., Bourantas K.L. The role of cytokines in sickle cell disease. Ann. Hematol. 79:2000;407-413.
11. Swerlick R.A., et al. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J. Immunol. 148:1992;78-83.
12. Salcedo R., et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14:2000;2055-2064.
13. Haraldsen G., et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. 156:1996;2558-2565.
14. Beck G.C., et al. Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin. Exp. Immunol. 118:1999;298-303.
15. Brittain H.A., Eckman J.R., Wick T.M. Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J. Lab. Clin. Med. 120:1992;538-545.
16. Malave I., et al. Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease. Acta Haematol. 90:1993;172-176.
17. Francis R.B. Jr., Haywood L.J. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J. Natl. Med. Assoc. 84:1992;611-615.
18. Croizat H. Circulating cytokines in sickle cell patients during steady state. Br. J. Haematol. 87:1994;592-597.
19. Ibe B.O., et al. Plasma and urinary leukotrienes in sickle cell disease possible role in the inflammatory process . Eur. J. Clin. Invest. 24:1994;57-64.
20. Enwonwu C.O., Lu M. Elevated plasma histamine in sickle cell anaemia. Clin. Chim. Acta. 203:1991;363-368.
21. Goebeler M., et al. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J. Invest. Dermatol. 108:1997;445-451.
22. Hettmannsperger U., et al. Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin 6 - inhibition by hydrocortisone, dexamethasone, and calcitriol. J. Invest. Dermatol. 99:1992;531-536.
23. Shukaliak J.A., Dorovini-Zis K. Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture. J. Neuropathol. Exp. Neurol. 59:2000;339-352.
24. Garcia G.E., et al. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J. Leukoc. Biol. 67:2000;577-584.
25. Ko Y., et al. Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. Mol. Cell Probes. 13:1999;203-211.
26. van Hinsbergh V.W., et al. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood. 72:1988;1467-1473.
27. Rajavashisth T.B., et al. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J. Biol. Chem. 274:1999;11924-11929.
28. Sarma V., et al. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J. Immunol. 148:1992;3302-3312.
29. Sultana C., et al. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood. 92:1998;3924-3935.
30. Duits A.J., et al. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin. Immunol. Immunopathol. 81:1996;96-98.
31. Duits A.J., et al. Elevated IL-8 levels during sickle cell crisis. Eur. J. Haematol. 61:1998;302-305.
32. Taylor S.C., et al. Serum interleukin-6 levels in the steady state of sickle cell disease. J. Interferon Cytokine Res. 15:1995;1061-1064.
33. Nsiri B., et al. Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease. Hematol. Cell Ther. 39:1997;229-232.
34. Haider M.Z., et al. GM-CSF in sickle cell anemia patients with elevated Hb F. Acta Haematol. 102:2000;140-143.
35. Croizat H., Nagel R.L. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia. Am. J. Hematol. 60:1999;105-115.
36. Abboud M.R., et al. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br. J. Haematol. 111:2000;482-490.
37. Abboud M., Laver J., Blau C.A. Granulocytosis causing sickle-cell crisis. Lancet. 351:1998;959.
38. Adler B.K., et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 97:2001;3313-3314.
39. Grigg A.P. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia. Blood. 97:2001;3998-3999.
40. Yonekura H., et al. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J. Biol. Chem. 274:1999;35172-35178.
41. de Leeuw H.P., et al. Small GTP-binding protein RalA associates with Weibel-Palade bodies in endothelial cells. Thromb. Haemost. 82:1999;1177-1181.
42. Gilbertson-Beadling S.K., Fisher C. A potential role for N-cadherin in mediating endothelial cell-smooth muscle cell interactions in the rat vasculature. Lab. Invest. 69:1993;203-209.
43. Swerlick R.A., et al. Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J. Invest. Dermatol. 99:1992;715-722.
44. Hornig C., et al. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab. Invest. 80:2000;443-454.
45. Wong Y.C., et al. cDna cloning of a novel cell adhesion protein expressed in human squamous carcinoma cells. Biochem. Biophys. Res. Commun. 166:1990;984-992.
46. Nath K.A., et al. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am. J. Pathol. 158:2001;893-903.
47. Manodori A.B., et al. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 95:2000;1293-1300.